Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 33,061,711 $ 19,444,737
Accounts receivable 14,238 7,118
Prepaid expenses 1,095,971 303,178
Other current assets 496,902 576,660
Total Current Assets 34,668,822 20,331,693
Property and equipment, net 5,249,398 5,171,134
Operating lease right-of-use assets 303,548 326,085
Intangible assets, net 288,003 321,641
Total Assets 40,509,771 26,150,553
Current Liabilities    
Accounts payable 1,463,963 1,539,547
Accrued liabilities 3,365,696 3,491,740
Management and directors' fees payable 39,484 55,174
Current portion of long-term debt 840,556 841,319
Current portion of finance lease liabilities 56,941 59,930
Current portion of operating lease liabilities 167,364 179,624
Current portion of grant repayable 66,475 69,218
Total Current Liabilities 6,000,479 6,236,552
Long-term debt, net of current portion 2,390,687 2,606,885
Finance lease liabilities, net of current portion 564,484 601,967
Operating lease liabilities, net of current portion 142,015 151,828
Grant repayable, net of current portion 249,313 259,603
Total Liabilities 9,346,978 9,856,835
STOCKHOLDERS' EQUITY    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 52,871,001 shares and 48,607,017 shares, respectively 52,871 48,607
Additional paid-in capital 147,382,487 126,526,239
Accumulated other comprehensive income 74,155 (59,978)
Accumulated deficit (116,290,117) (110,173,971)
Total VolitionRx Limited Stockholders' Equity 31,219,396 16,340,897
Non-controlling interest (56,603) (47,179)
Total Stockholders' Equity 31,162,793 16,293,718
Total Liabilities and Stockholders' Equity $ 40,509,771 $ 26,150,553